# 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

> **NCT00967577** · PHASE1 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 20 (actual)

## Conditions studied

- Kidney Cancer
- Head and Neck Cancer
- Breast Cancer
- Non-small Cell Lung Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Esophageal Cancer
- Gliomas

## Interventions

- **DRUG:** 177Lu-J591

## Key facts

- **NCT ID:** NCT00967577
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2018-06
- **Final completion:** 2021-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967577, "177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00967577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*